PSPH

Phosphoserine phosphatase · P78330 · PSPH on Sugi Atlas →

0 patent compounds predicted against PSPH, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PSPH by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis PHASE3RECRUITING
Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients PHASE3ACTIVE_NOT_RECRUITING
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer PHASE2/PHASE3UNKNOWN
Proteome-based Immunotherapy of Lung Cancer Brain Metastases PHASE2/PHASE3UNKNOWN
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis PHASE1/PHASE2COMPLETED
Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis PHASE2COMPLETED
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas PHASE2COMPLETED
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE2COMPLETED
Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy PHASE1/PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma nanCOMPLETED
IVF Outcome in Polycystic Ovary Syndrome Patients nanUNKNOWN
Planetary Habitat Simulation: Bone Metabolism Studies nanCOMPLETED
Presepsin:Gelsolin Ratio in Sepsis-related Organ Dysfunction nanCOMPLETED
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
MOLECULAR REGULATION OF MUSCLE GLUCOSE METABOLISM (AIMS 2A, 2B, 3) nanUNKNOWN
Evaluating Changes in Skeletal Muscle Proteins Following Resistance Exercise and Single-Leg Disuse nanCOMPLETED
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Long Term Prediction of MASH-related HCC Risk by Proteomics nanNOT_YET_RECRUITING
Risk Factors for Progressive Supranuclear Palsy (PSP) nanCOMPLETED
A Retrospective Study to Identify New Omics Biomarkers of Chronic/Persistent Low Back Pain nanCOMPLETED
Glucose-dependent Asprosin Dynamics nanCOMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer nanACTIVE_NOT_RECRUITING
Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome nanUNKNOWN
Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients nanUNKNOWN
Protein Intake and Step Reduction in Older Adults nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PSPH binder may also engage these)

ProteinNameSimilarity
Q5RB83 1.000 Q5RB83 →
Q5M819 1.000 Q5M819 →
Q99LS3 1.000 Q99LS3 →
Q2KHU0 0.999 Q2KHU0 →
Q9D020 0.959 Q9D020 →
B9N1F9 0.955 B9N1F9 →
PMM2 Phosphomannomutase 2 0.953 landscape →
O35621 0.951 O35621 →
Q60HD6 0.950 Q60HD6 →
Q9H0P0 0.949 Q9H0P0 →
A0A0U1WZ18 0.949 A0A0U1WZ18 →
Q5ZID6 0.949 Q5ZID6 →
A0A0K9RL25 0.949 A0A0K9RL25 →
Q7SYN4 0.948 Q7SYN4 →
E0CSI1 0.948 E0CSI1 →
Q92871 0.948 Q92871 →
Q5BJJ5 0.947 Q5BJJ5 →
Q3UGR5 0.947 Q3UGR5 →
Q6AYR6 0.947 Q6AYR6 →
Q3ZCH9 0.946 Q3ZCH9 →
Q8GWU0 0.946 Q8GWU0 →
P0DKC4 0.946 P0DKC4 →
Q6P8M1 0.946 Q6P8M1 →
O80840 0.945 O80840 →
Q9H0R4 0.945 Q9H0R4 →
P0DKC3 0.945 P0DKC3 →
Q8R4N0 0.945 Q8R4N0 →
Q5ZKF6 0.945 Q5ZKF6 →
Q2R483 0.944 Q2R483 →
Q5R4B4 0.944 Q5R4B4 →